Format

Send to

Choose Destination
Cancer Res. 2000 Nov 1;60(21):5946-9.

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

Author information

1
Breast Cancer Research Program of the University of Soulthern California/Norris Comprehensive Cancer Center, Los Angeles 90089-9176, USA.

Abstract

In the present study, the role of BRCA1 in ligand-dependent androgen receptor (AR) signaling was assessed. In transfected prostate and breast cancer cell lines, BRCA1 enhanced AR-dependent transactivation of a probasin-derived reporter gene. The effects of BRCA1 were mediated through the NH2-terminal activation function (AF-1) of the receptor. Cotransfection of p160 coactivators markedly potentiated BRCA1-mediated enhancement of AR signaling. In addition, BRCA1 was shown to interact physically with both the AR and the p160 coactivator, glucocorticoid receptor interacting protein 1. These findings suggest that BRCA1 may directly modulate AR signaling and, therefore, may have implications regarding the proliferation of normal and malignant androgen-regulated tissues.

PMID:
11085509
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center